Global /United States /Healthcare /Medical Devices /BIO
chevron_leftBack
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc.

BIO
NYSE: BIO Delayed
275.15USD -1.5%
As of 6 June 2026, Bio-Rad Laboratories, Inc. has a market cap of $7.43B USD, ranking #2799 globally and #871 in the United States. It ranks #205 in the Healthcare sector, and #49 in the Medical Devices industry.
Global Rank
2799
Country Rank
871
Sector Rank
205
Industry Rank
49
Key Stats
Market Cap
$7.43BUSD
Enterprise Value
$7.23BUSD
Revenue (TTM)
$2.58BUSD
EBITDA (TTM)
$431.6MUSD
Net Income (TTM)
$759.9MUSD
EBITDA Margin
17%
Profit Margin
29%
PE Ratio
9.9
Forward PE
26.8
PS Ratio
2.9
PB Ratio
1.0
EV/EBITDA
16.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Norman Schwartz open_in_new
Employees
7,450
Founded
1952
Website
bio-rad.com open_in_new
1d 1w 1m 3m 6m 1y
-1.5% -8.7% 3.5% -8.4% -17% 14%

News

Loading...

BIO Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
BIO
Bio-Rad Laboratories Inc Class A
ISIN: US0905722072
Shares Out.:
21.701M1 Shares Float: 17.916M2
TV:
SA:
YF:
BIO
GF:
NQ:
BIO
BA:
BIO
MS:
275.15 USD
NYSE
MIC: XNYS
BIO.B
Bio-Rad Laboratories Inc
ISIN: US0905721082
Shares Out.:
5.061M1 Shares Float: 94.626K2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
304.15 USD
Frankfurt Stock Exchange
MIC: XFRA
BUW
Bio-Rad Laboratories Inc
ISIN: US0905721082
TV:
SA:
YF:
GF:
BA:
BUW
MS:
218.00 EUR
Show all 4 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
2K%
25.8
$160.73B
2K%
56.7
$159.07B
2K%
25.6
DHR
$126.55B
2K%
34.7
SYK
$120.69B
2K%
38.3
$84.93B
1K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
1K%
22.2
$97.94B
84.32B EUR
1K%
36.7
7741
$61.43B
9.83T JPY
727%
40.0
$45.7B
39.34B EUR
515%
18.7
ALC
$36.73B
28.99B CHF
395%
37.9
$30.09B
203.66B CNY
305%
26.0
chevron_leftBack